To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.
Clinical trial NCT07055243 · RECRUITING
Trial details
- NCT number
- NCT07055243
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-26
- Primary completion
- 2026-06-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.